【摘要】 目的 探究宮腹腔鏡下微創(chuàng)手術(shù)治療子宮肌瘤的臨床效果。方法 320例子宮肌瘤患者作為研究對(duì)象， 隨機(jī)分為對(duì)照組和觀(guān)察組， 各160例。對(duì)照組采用常規(guī)的開(kāi)腹手術(shù)治療， 觀(guān)察組采用宮腹腔鏡下微創(chuàng)手術(shù)治療。比較兩組患者的手術(shù)指標(biāo)、并發(fā)癥發(fā)生情況以及臨床療效。結(jié)果 觀(guān)
　　察組術(shù)中出血量（69.96±2.57）ml、手術(shù)時(shí)間（77.25±3.71）min、住院時(shí)間（3.51±0.95）d優(yōu)于對(duì)照組的（99.25±2.18）ml、（96.84±2.93）min、（10.64±1.28）d， 差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。觀(guān)察組并發(fā)癥發(fā)生率3.12 %顯著低于對(duì)照組的11.86 %， 差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。觀(guān)察組痊愈130例、有效20例、
　　無(wú)效10例， 治療總有效率為93.75%;對(duì)照組痊愈100例、有效19例、無(wú)效41例， 治療總有效率為74.38%。觀(guān)察組治療總有效率顯著高于對(duì)照組， 差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論 采用宮腹腔鏡下微創(chuàng)手術(shù)治療子宮肌瘤患者可有效減少術(shù)中出血量， 減少手術(shù)時(shí)間以及術(shù)后的恢復(fù)時(shí)間， 降低并發(fā)癥發(fā)生率， 臨床療效顯著， 值得推廣。
　　【關(guān)鍵詞】 子宮肌瘤;宮腹腔鏡;微創(chuàng)手術(shù);臨床效果
　　DOI：10.14163/j.cnki.11-5547/r.2018.12.004
　　【Abstract】 Objective To investigate the clinical effect of laparoscopic minimally invasive surgery for the treatment of uterine myoma. Methods A total of 320 uterine myoma patients as study subjects were randomly divided into control group and observation group， with 160 cases in each group. The control group received conventional laparotomy， and the observation group received laparoscopic minimally invasive surgery. Comparison were made on surgical indicators， occurrence of complications and clinical efficacy between the two groups. Results The observation group had obviously better intraoperative bleeding volume as （69.96±2.57） ml，
　　operation time as （77.25±3.71） min and hospitalization time as （3.51±0.95） d than （99.25±2.18） ml，
　　（96.84±2.93） min and （10.64±1.28） d in the control group， and their difference was statistically significant （P<0.05）. The observation group had obviously lower incidence of complications as 3.12% than 11.86% in the control group， and the difference was statistically significant （P<0.05）. The observation group had 130 cure cases， 20 effective cases and 10 ineffective cases， with total treatment effective rate as 93.75%， which were 100， 19， 41 cases and 74.38% in the control group. The observation group had obviously higher total treatment effective rate than the control group， and the difference was statistically significant （P<0.05）. Conclusion Laparoscopic minimally invasive surgery shows remarkable clinical efficacy in treating uterine myoma， and it can effectively reduce intraoperative bleeding volume， reduce operation time and postoperative recovery time， lower incidence of complications. It is worthy of promotion.
　　【Key words】 Uterine myoma; Laparoscopy; Minimally invasive surgery; Clinical effect
　　子宮肌瘤在臨床學(xué)中也被稱(chēng)為子宮平滑肌瘤， 屬于女性生殖系統(tǒng)良性腫瘤。臨床中常見(jiàn)的患者大多在30～50歲， 患者在臨床中的表現(xiàn)主要是月經(jīng)過(guò)多及經(jīng)期延長(zhǎng)， 一部分患者還會(huì)出現(xiàn)腹部捫及腫物， 因肌瘤壓迫導(dǎo)致尿頻、尿急或排尿困難， 若不及時(shí)進(jìn)行治療會(huì)導(dǎo)致腫瘤發(fā)生變性， 甚至發(fā)展成為惡性腫瘤， 對(duì)女性的身心健康造成了嚴(yán)重的危害[1， 2]。在過(guò)去臨床中一般采用開(kāi)腹手術(shù)進(jìn)行治療， 但開(kāi)腹手術(shù)存在風(fēng)險(xiǎn)較大、術(shù)后并發(fā)癥較多、切口容易感染、術(shù)后恢復(fù)較慢、對(duì)生育能力影響較大等缺點(diǎn)， 且滿(mǎn)足不了現(xiàn)代女性的審美需求。隨著時(shí)代的變化醫(yī)學(xué)技術(shù)也在不斷發(fā)展， 現(xiàn)代化的微創(chuàng)手術(shù)在臨床中的應(yīng)用也越來(lái)越廣泛， 本研究中采用宮腹腔鏡下微創(chuàng)手術(shù)治療效果顯著， 現(xiàn)報(bào)告如下。

相關(guān)熱詞搜索：腹腔 子宮肌瘤 臨床 微創(chuàng) 觀(guān)察